close 74% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Dashboard

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

Strona główna・Stock List・CIDARA THERAPEUTICS INC
Search

CIDARA THERAPEUTICS INC

Closed

SectorHealthcare

19.21 1.86

Strong Buy

Price update 8 maj 2025, 19:57 UTC

BuySell

Overview

Share price change

24h

Current

Min

18.34

Max

19.98

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+97.58% upside

News Sentiment

By Acuity

49%

51%

194 / 382 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

N/A / 21.48 Support & Resistance

CIDARA THERAPEUTICS INC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 maj 2025, 23:59 UTC

Top News
Earnings

Naver 1Q Net Slumps on Higher Costs

DJ

Read

8 maj 2025, 23:39 UTC

Earnings

OCBC 1Q Net Down on Lower Interest Income

DJ

Read

8 maj 2025, 23:01 UTC

Earnings

Macquarie Raises Dividend After 5.5% Rise in Annual Profit -- Update

DJ

Read

8 maj 2025, 22:52 UTC

Earnings

REA Expects Annual Listings Growth Despite April Decline

DJ

Read

8 maj 2025, 22:46 UTC

Earnings

Macquarie Raises Dividend After 5.5% Rise in Annual Profit

DJ

Read

8 maj 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

8 maj 2025, 23:45 UTC

Market Talk

Nikkei May Rise as Tariffs Fears Ease -- Market Talk

DJ

Read

8 maj 2025, 23:41 UTC

Market Talk

Gold Rises on Possible Technical Recovery; Gains May be Capped by Risk-on Mood -- Market Talk

DJ

Read

8 maj 2025, 23:30 UTC

Earnings

Itau Unibanco 1Q Rev BRL45.02B >ITUB

DJ

Read

8 maj 2025, 23:29 UTC

Earnings

Itau Unibanco 1Q EPS BRL1.03 >ITUB

DJ

Read

8 maj 2025, 23:22 UTC

Earnings

Naver 1Q Net Profit Largely Met FactSet-Compiled Consensus

DJ

Read

8 maj 2025, 23:22 UTC

Earnings

Naver 1Q Net KRW423.70B Vs. Net KRW555.80B >035420.SE

DJ

Read

8 maj 2025, 23:21 UTC

Earnings

Naver 1Q Oper Pft KRW505.30B Vs. Pft KRW439.30B >035420.SE

DJ

Read

8 maj 2025, 23:21 UTC

Earnings

Naver 1Q Rev KRW2.787T Vs. KRW2.526T >035420.SE

DJ

Read

8 maj 2025, 23:17 UTC

Earnings

Oversea-Chinese Banking Corp. 1Q Net Interest Income S$2.35B Vs. S$2.44B >O39.SG

DJ

Read

8 maj 2025, 23:17 UTC

Earnings

Oversea-Chinese Banking Corp. 1Q Total Income S$3.66B Vs. S$3.63B >O39.SG

DJ

Read

8 maj 2025, 23:17 UTC

Earnings

Oversea-Chinese Banking Corp. 1Q Net S$1.88B Vs. Net S$1.98B >O39.SG

DJ

Read

8 maj 2025, 23:05 UTC

Market Talk

ANZ Could Cut Dividend by 10% From 2H -- Market Talk

DJ

Read

8 maj 2025, 23:05 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

8 maj 2025, 22:28 UTC

Earnings

REA Expects FY 2025 Listings Growth of 1-2%

DJ

Read

8 maj 2025, 22:28 UTC

Earnings

REA Says April Listings Decline Reflects Year Ago Strength, Timing of Easter and Election

DJ

Read

8 maj 2025, 22:27 UTC

Earnings

REA Says April Sydney, Melbourne Listings Both Down 16% on Year

DJ

Read

8 maj 2025, 22:27 UTC

Earnings

REA Says April Residential Listings Fell by 11% on Year

DJ

Read

8 maj 2025, 22:26 UTC

Earnings

REA 3Q Operating Expenses A$176 Million, Up 12% on Year

DJ

Read

8 maj 2025, 22:26 UTC

Earnings

REA 3Q Free Cash Flow A$132 Million, Up 19% on Year

DJ

Read

8 maj 2025, 22:26 UTC

Earnings

REA 3Q Operating Ebitda A$199 Million, Up 12% on Year

DJ

Read

8 maj 2025, 22:26 UTC

Earnings

REA Nine-Months Free Cash Flow A$389 Million, Up 21% on Year

DJ

Read

8 maj 2025, 22:25 UTC

Earnings

REA Nine-Months Operating Expenses A$513 Million, Up 15% on Year

DJ

Read

8 maj 2025, 22:25 UTC

Earnings

REA Nine-Months Operating Ebitda A$734 Million, Up 19% on Year

DJ

Read

8 maj 2025, 22:25 UTC

Earnings

REA 3Q Revenue A$374 Million, Up 12% on Year

DJ

Read

Peer Comparison

Price change

CIDARA THERAPEUTICS INC Forecast

Price Target

By TipRanks

97.58% upside

12 Months Forecast

Average 37.5 USD  97.58%

High 46 USD

Low 34 USD

Based on 5 Wall Street analysts offering 12 month price targets forCIDARA THERAPEUTICS INC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Based on 5 analysts giving stock ratings to CIDARA THERAPEUTICS INC - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 21.48Support & Resistance

Short Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

Strong Bullish Evidence

All events are bullish.

Sentiment

By Acuity

194 / 382 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

$

Other stocks from the sector

LLY

Eli Lilly and Co.

751.96

↓-3.18%

JNJ

Johnson and Johnson

155.56

↓-1.06%

UNH

UnitedHealth Group Inc

385.73

↓-1.37%

ABBV

AbbVie Inc

185.44

↓-1.29%

ABT

Abbott Laboratories

133.82

↓-0.01%